Pacific Biosciences of California (PACB) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Pacific Biosciences of California Revenue Highlights


Latest Revenue (Y)

$200.52M

Latest Revenue (Q)

$38.81M

Main Segment (Y)

Product

Main Geography (Y)

North America

Pacific Biosciences of California Revenue by Period


Pacific Biosciences of California Revenue by Year

DateRevenueChange
2023-12-31$200.52M56.29%
2022-12-31$128.30M-1.69%
2021-12-31$130.51M65.43%
2020-12-31$78.89M-13.20%
2019-12-31$90.89M15.60%
2018-12-31$78.63M-15.88%
2017-12-31$93.47M3.04%
2016-12-31$90.71M-2.23%
2015-12-31$92.78M53.12%
2014-12-31$60.59M115.02%
2013-12-31$28.18M8.46%
2012-12-31$25.98M-23.27%
2011-12-31$33.86M1922.88%
2010-12-31$1.67M1140.00%
2009-12-31$135.00K-85.02%
2008-12-31$901.00K-58.34%
2007-12-31$2.16M-

Pacific Biosciences of California generated $200.52M in revenue during NA 2023, up 56.29% compared to the previous quarter, and up 255.03% compared to the same period a year ago.

Pacific Biosciences of California Revenue by Quarter

DateRevenueChange
2024-03-31$38.81M-33.50%
2023-12-31$58.36M4.79%
2023-09-30$55.69M17.06%
2023-06-30$47.57M22.30%
2023-03-31$38.90M42.21%
2022-12-31$27.35M-15.34%
2022-09-30$32.31M-8.90%
2022-06-30$35.47M6.92%
2022-03-31$33.17M-7.90%
2021-12-31$36.02M3.24%
2021-09-30$34.89M13.97%
2021-06-30$30.61M5.56%
2021-03-31$29.00M6.86%
2020-12-31$27.14M42.21%
2020-09-30$19.08M11.74%
2020-06-30$17.08M9.48%
2020-03-31$15.60M-44.15%
2019-12-31$27.93M27.45%
2019-09-30$21.91M-10.99%
2019-06-30$24.62M49.90%
2019-03-31$16.43M-15.88%
2018-12-31$19.53M7.52%
2018-09-30$18.16M-15.84%
2018-06-30$21.58M11.45%
2018-03-31$19.36M-22.35%
2017-12-31$24.93M5.90%
2017-09-30$23.55M17.30%
2017-06-30$20.07M-19.43%
2017-03-31$24.91M-3.14%
2016-12-31$25.72M2.40%
2016-09-30$25.12M21.07%
2016-06-30$20.75M8.47%
2016-03-31$19.13M-47.28%
2015-12-31$36.28M160.70%
2015-09-30$13.92M-44.20%
2015-06-30$24.94M41.34%
2015-03-31$17.64M4.38%
2014-12-31$16.90M-18.03%
2014-09-30$20.62M80.51%
2014-06-30$11.43M-1.86%
2014-03-31$11.64M27.47%
2013-12-31$9.13M23.07%
2013-09-30$7.42M22.70%
2013-06-30$6.05M8.43%
2013-03-31$5.58M-5.10%
2012-12-31$5.88M111.74%
2012-09-30$2.78M-61.93%
2012-06-30$7.29M-27.37%
2012-03-31$10.04M-19.33%
2011-12-31$12.44M18.30%
2011-09-30$10.52M-1.04%
2011-06-30$10.63M3837.04%
2011-03-31$270.00K-3.57%
2010-12-31$280.00K27.27%
2010-09-30$220.00K-65.02%
2010-06-30$629.00K15.41%
2010-03-31$545.00K303.70%
2009-12-31$135.00K100.00%
2009-09-30--

Pacific Biosciences of California generated $38.81M in revenue during Q1 2024, up -33.50% compared to the previous quarter, and up 141.89% compared to the same period a year ago.

Pacific Biosciences of California Revenue Breakdown


Pacific Biosciences of California Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21Dec 20Dec 19Dec 18
Instrument$48.72M$61.32M$34.28M$45.13M$28.49M
Product$108.70M$113.50M$65.42M$77.74M$66.36M
Consumable$59.98M$52.18M$31.14M$32.62M$37.86M
Service And Other$19.61M$17.01M$13.47M$13.15M$12.27M

Pacific Biosciences of California's latest annual revenue breakdown by segment (product or service), as of Dec 22: Product (45.86%), Consumable (25.31%), Instrument (20.56%), and Service And Other (8.27%).

Quarterly Revenue by Product

Product/ServiceMar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18
Instrument$19.02M$34.69M$29.92M$20.70M$11.44M$15.62M$15.55M$45.15M$14.28M$14.94M$7.73M$8.93M$4.02M$11.58M$12.66M$5.62M$6.53M---
Service And Other$3.80M$4.13M$3.92M$4.25M$4.58M$4.80M$5.29M$4.93M$4.38M$4.08M$3.69M$3.51M$3.33M$3.32M$3.31M$3.38M$3.43M$3.37M$2.97M$3.09M
Consumable$15.98M$16.87M$13.73M$13.95M$16.07M$14.56M$12.69M$37.19M$12.25M$10.36M$8.02M$4.82M$8.27M$6.90M$8.59M$7.83M$9.91M---
Product$35.01M$51.56M$43.66M$34.65M$22.77M$27.51M$30.18M$28.24M$30.50M$26.53M$25.30M$23.63M$15.75M$13.76M$12.29M$24.55M$18.48M$21.25M$13.46M$16.44M

Pacific Biosciences of California's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (47.43%), Instrument (25.77%), Consumable (21.65%), and Service And Other (5.15%).

Pacific Biosciences of California Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Dec 21Dec 20Dec 19Dec 18
Asia Pacific$36.15M$35.72M$22.55M$26.61M$29.07M
North America$69.56M$64.52M$37.28M$44.68M$35.60M
Europe$22.60M$30.27M$19.07M$19.60M$13.96M

Pacific Biosciences of California's latest annual revenue breakdown by geography, as of Dec 22: North America (54.22%), Asia Pacific (28.17%), and Europe (17.61%).

Quarterly Revenue by Country

CountryMar 24Sep 23Jun 23Mar 23Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Sep 20Jun 20Mar 20Sep 19Jun 19Mar 19Sep 18Jun 18Mar 18
Asia Pacific$12.78M$15.72M$12.88M$11.96M$9.57M$8.01M$8.39M$9.17M$9.77M$8.52M$5.77M$4.43M$4.44M$6.58M$6.99M$4.37M$6.29M$8.69M$7.60M
EMEA$8.36M$10.99M$10.73M$7.87M---------------
Americas$17.68M$28.98M$23.96M$19.07M---------------
North America----$16.74M$21.72M$19.08M$19.37M$14.35M$12.16M$8.97M$8.46M$7.76M$10.39M$14.22M$8.99M$8.96M$9.20M$7.80M
Europe----$6.00M$5.74M$5.70M$6.35M$6.49M$8.32M$4.34M$4.19M$3.40M$4.94M$3.41M$3.06M$2.91M$3.69M$4.00M

Pacific Biosciences of California's latest quarterly revenue breakdown by geography, as of Mar 24: Americas (45.55%), Asia Pacific (32.92%), and EMEA (21.53%).

Pacific Biosciences of California Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
CRSPCRISPR Therapeutics$370.00M$517.00K
TWSTTwist Bioscience$245.11M$81.46M
PACBPacific Biosciences of California$200.52M$38.81M
NTLAIntellia Therapeutics$36.27M$6.96M
EDITEditas Medicine-$513.00K

PACB Revenue FAQ


Pacific Biosciences of California's yearly revenue for 2023 was $200.52M, representing an increase of 56.29% compared to 2022. The company's yearly revenue for 2022 was $128.3M, representing a decrease of -1.69% compared to 2021. PACB's yearly revenue for 2021 was $130.51M, representing an increase of 65.43% compared to 2020.

Pacific Biosciences of California's quarterly revenue for Q1 2024 was $38.81M, a -33.50% decrease from the previous quarter (Q4 2023), and a -0.23% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $58.36M, a 4.79% increase from the previous quarter (Q3 2023), and a 113.35% increase year-over-year (Q4 2022). PACB's quarterly revenue for Q3 2023 was $55.69M, a 17.06% increase from the previous quarter (Q2 2023), and a 72.36% increase year-over-year (Q3 2022).

Pacific Biosciences of California's revenue growth rate for the last 3 years (2021-2023) was 53.64%, and for the last 5 years (2019-2023) was 120.62%.

Pacific Biosciences of California's revenue streams in c 22 are Instrument, Product, Consumable, and Service And Other. Instrument generated $48.72M in revenue, accounting 20.56% of the company's total revenue, down -20.55% year-over-year. Product generated $108.7M in revenue, accounting 45.86% of the company's total revenue, down -4.23% year-over-year. Consumable generated $59.98M in revenue, accounting 25.31% of the company's total revenue, up 14.95% year-over-year. Service And Other generated $19.6M in revenue, accounting 8.27% of the company's total revenue, up 15.27% year-over-year.

For the fiscal year ending Dec 22, the largest source of revenue of Pacific Biosciences of California was Product. This segment made a revenue of $108.7M, representing 45.86% of the company's total revenue.